A study assessing CT angiographs of nearly 25,000 patients presumed to be free of coronary artery disease (CAD) has shown both obstructive and nonobstructive forms of the disease to increase the risk of death.
A study assessing CT angiographs of nearly 25,000 patients presumed to be free of coronary artery disease (CAD) has shown both obstructive and nonobstructive forms of the disease to increase the risk of death.
The study, published August 16 in the Journal of the American College of Cardiology, used data from CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry). The cohort included 24,775 patients from 12 centers, average age 57. From 2005 to 2009, all underwent noninvasive imaging with coronary computed tomography angiography (CCTA).
Researches led by radiologist James K. Min, MD, of Cedars-Sinai Medical Center in Los Angeles, Calif., followed up 2.3 years after the patients’ CT angiographs. At that point, 404 of the patients had died of various causes. Min and colleagues found that patients who indeed had been healthy - that is, no discernable CAD in CT angiographs - had a low annualized death rate of 0.28 percent.
Those with nonobstructive and obstructive CAD fared worse. Those with nonobstructive CAD had hazard ratios averaging 1.62 (that is, a risk of death 62 percent higher than healthy controls in the 2.3-year time frame assessed). Those with one obstructed vessel had a hazard ratio (HR) of 2.0, those with two obstructed vessels 2.92, and those with three obstructed vessels 3.70.
Min and colleagues also found that patients younger than 65 years old had higher death rates for two- and three-vessel obstructive CAD, possibly because of more aggressive forms of atherosclerosis. Also, the study found that women with three-vessel obstructions faced more serious risk than men.
“That coronary CT angiography can effectively risk stratify individuals without known CAD should be invaluable for guiding the development of clinical practice guidelines and appropriate use criteria,” the authors concluded.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Enhanced Mobile CT System with High-Resolution Photon-Counting Technology
July 15th 2024Photon-counting CT-optimized features with the OmniTom Elite system include 30 cm field of view scanning, continuous spiral scanning, and an ultra-high-resolution capability of 0.141 mm resolution.